Literature DB >> 27155384

Secondary Chondrosarcoma of the Upper Thoracic Costovertebral Junction with Neural Foraminal Extension and Compressing the Spinal Cord.

Sofiene Bouali1, Asma Bouhoula2, Nidhal Maatar2, Khansa Abderrahmen2, Adnen Boubaker2, Jalel Kallel2, Hafedh Jemel2.   

Abstract

BACKGROUND: Chondrosarcoma is a rare malignant tumor of bone. This family of tumors can be primary malignant tumors or a secondary malignant transformation of an underlying benign cartilage tumor. Secondary chondrosarcoma arising from a benign solitary costal osteochondroma is extremely rare. Data show that the reported incidence of costal osteochondroma is very low and they are usually found in the anterior region at the costochondral junction. To our knowledge, however, there have been no previous reports, in English literature, describing osteochondroma malignant transformation located in the thoracic costovertebral junction. CASE DESCRIPTION: We report the case of a man with chondrosarcoma arising from the malignant degeneration of an osteochondroma at the right first thoracic costovertebral junction with neural foraminal extension and compressing the spinal cord.
CONCLUSIONS: Although it is rare in solitary osteochondromas of rib, malignant transformation must always be considered.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chondrosarcoma; Magnetic resonance imaging; Osteochondroma; Surgery

Mesh:

Year:  2016        PMID: 27155384     DOI: 10.1016/j.wneu.2016.04.105

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  2 in total

1.  Surgical treatment of chondrosarcoma of the sacrum with cement augmentation: A case report.

Authors:  Shuzhong Liu; Xi Zhou; An Song; Zhen Huo; Yipeng Wang; Yong Liu
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

2.  Surgical treatment of metastatic mesenchymal chondrosarcoma to the spine: A case report.

Authors:  Shuzhong Liu; Xi Zhou; An Song; Zhen Huo; Yipeng Wang; Yong Liu
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.